Bile secretion is regulated by different signaling transduction pathways including protein kinase C (PKC). However, the role of different PKC isoforms for bile formation is still controversial. This study investigates the effects of PKC isoform selective activators and inhibitors on PKC translocation, bile secretion, bile acid uptake, and subcellular transporter localization in rat liver, isolated rat hepatocytes and in HepG2 cells. In rat liver activation of Ca 2؉ -dependent cPKC␣ and Ca 2؉ -independent PKC⑀ by phorbol 12-myristate 13-acetate (PMA, 10nmol/liter) is associated with their translocation to the plasma membrane. PMA also induced translocation of the cloned rat PKC⑀ fused to a yellow fluorescent protein (YFP), which was transfected into HepG2 cells. In the perfused liver, PMA induced marked cholestasis. The PKC inhibitors Gö 6850 (1 mol/liter) and Gö 6976 (0.2 mol/liter), a selective inhibitor of Ca 2؉ -dependent PKC isoforms, diminished the PMA effect by 50 and 60%, respectively. Thymeleatoxin (Ttx,) a selective activator of Ca 2؉ -dependent cPKCs, did not translocate rat PKC⑀-YFP transfected in HepG2 cells. However, Ttx (0.5-10 nmol/liter) induced cholestasis similar to PMA and led to a retrieval of Bsep from the canalicular membrane in rat liver while taurocholate-uptake in isolated hepatocytes was not affected. Gö 6976 completely blocked the cholestatic effect of Ttx but had no effect on tauroursodeoxycholate-induced choleresis. The data identify Ca 2؉ -dependent PKC isoforms as inducers of cholestasis. This is mainly due to inhibition of taurocholate excretion involving transporter retrieval from the canalicular membrane.
Cholestasis is a major clinical issue and results from dysregulation of transporter proteins in the sinusoidal (1) and the canalicular membranes (2) . Long term down-regulation of these transport systems involves changes in mRNA and protein levels (3, 4) while short term regulation is achieved by transporter retrieval and possibly covalent modification of transporter proteins (5, 6) . In some forms of cholestasis retrieval of transporter proteins precedes their expressional down-regulation (7) . Although many inducers of short term cholestasis are known (7) (8) (9) (10) , the underlying signal transduction mechanisms are incompletely understood.
Several studies related cholestasis to the action of protein kinase C (PKC) 1 (11) (12) (13) . The first PKC isoform was isolated by Nishizuka (14) . Subsequently, 12 isoforms were characterized and grouped into classical, Ca 2ϩ -dependent (cPKC: ␣, ␤ I , ␤ II , ␥), novel, Ca 2ϩ -independent (nPKC: ⑀, ␦, , ), and atypical (aPKC: , ) PKCs. In rat hepatocytes expression of PKC␣, ␤ II , ␦, ⑀ and was demonstrated (15, 16) . Stimulation of the Ca 2ϩ -independent PKC⑀ isoform by taurolithocholate was reported to decrease bile flow (12) , while the therapeutically used bile acid tauroursodeoxycholate (TUDC) increases bile flow (17, 18) . The choleretic effect of TUDC is mediated by MAP kinases of the Erk-type (18) and by the p38 MAPK (17) , while an anticholestatic effect of TUDC was attributed to the activation of the Ca 2ϩ -dependent PKC␣ (19, 20) . Thus, controversy exists regarding the role of individual PKC isoforms in bile secretion. In this study, the effects of PKC isoforms on bile formation were studied. Ca 2ϩ -dependent PKCs were found to trigger cholestasis and (in contrast to previous data (19, 20) ) were not involved in the choleretic response to TUDC.
EXPERIMENTAL PROCEDURES
Materials-Phorbol 12-myristate 13-acetate (PMA), Gö6976, and thymeleatoxin were from Calbiochem (Bad Soden, Germany), Gö6850 and the mouse anti MRP2/Mrp2 (M2III-6) antibody were from Alexis (Grü nberg, Germany). The rabbit anti-rat Bsep antibody (K12) and the rabbit anti-rat Ntcp (K4) were generous gifts from Dr. B. Stieger and Prof. P. Meier-Abt (Kantonsspital Zü rich, Switzerland). The anti-mouse ZO-1 antibody was from Biozol (Eching, Germany). Isoform-specific PKC antibodies were from BD Biosciences (Heidelberg, Germany). The plasmid MARCKS-GFP was generously provided by Prof. N. Saito (Kobe University, Japan) (21) .
Rat Liver Perfusion-Livers of male Wistar rats (150 g) were perfused as described previously (18) in the presence of 100mol/liter of taurocholate. Bile was collected every 2 min. Liver viability was assessed from the measurements of portal pressure, pH, and LDH-and glucose-release. After 30 min of perfusion, inhibitors or agonists were added to the medium as indicated. At various time points liver specimens were excised and snap frozen for cryosections or Western blots as described in Refs. 7 and 9.
Isolation and Culture of Rat Hepatocytes-Rat hepatocytes were * This study was supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 Experimentelle Hepatologie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 The abbreviations used are: PKC, protein kinase C; Bsep, bile salt export pump; Mrp2, multidrug resistance-associated protein 2; Ntcp, sodium taurocholate cotransporting polypeptide; cPKC, classical Ca 2ϩ -dependent protein kinase C; nPKC, novel Ca 2ϩ -independent protein kinase C; aPKC, atypical protein kinase C; MARCKS, myristoylated alanine-rich C kinase substrate; PMA, phorbol 12-myristate 13-acetate; Ttx, thymeleatoxin; ZO-1, zona occludens protein 1 associated with the tight junctions; YFP, yellow fluorescent protein; TC, taurocholate; TUDC, tauroursodeoxycholate. prepared as described previously (18) . Hepatocytes were cultured for 24 h in Dulbecco's modified Eagle's medium (containing 10% fetal bovine serum, 6 mmol/liter glucose, 100 units/ml penicillin, 100 g/ml streptomycin, 100 nmol/liter dexamethasone, and 100 nmol/liter insulin). FBS was omitted 12 h before experiments were started.
Western Blot Analysis and Densitometry-Liver specimen were minced in homogenization buffer containing Tris (20 mmol/liter, pH 7.4), sucrose (250 mmol/liter), EGTA (5 mmol/liter), MgCl 2 (1 mmol/ liter), and protease inhibitors according to Ref. 12 . Samples were ultracentrifuged for 60 min at 150,000 ϫ g. The pellets were enriched in cell membrane-bound proteins while supernatants contained cytosolic proteins. Equal protein amounts of the membranous or cytosolic fractions were separated by SDS-PAGE. PKC isoforms were detected by specific monoclonal antibodies. Densitometry was performed with 1D Image Analysis Software (PerkinElmer Optoelectronics, Wiesbaden, Germany). The amount of membrane-bound (mb) PKC isoforms is expressed as the intensity ratio I mb /(I mb ϩ I cytosolic ) or as the x-fold change compared with control. The total amount of PKC in cultured rat hepatocytes was determined in whole cell lysates.
Uptake Studies in Isolated Hepatocytes-Rat hepatocytes cultured for 12 h in fetal calf serum-free medium were treated with PMA, Ttx, or Me 2 SO (control) for 30 min and were then incubated for 2-10 min in fresh medium containing 150 mol/liter taurocholate (TC) and 450 cpm/fmol [ 3 H]TC. Uptake was stopped by removing the medium and washing the cells three times with ice-cold phosphate-buffered saline. Cells were lysed in a buffer containing 0.2 mol/liter NaOH and 0.05% SDS. Radioactivity of supernatants and cell lysates were measured in a scintillation counter (Packard instruments, Frankfurt, Germany). Unspecific binding of taurocholate was determined by incubating the cells in ice-cold incubation medium for 5 s. These values were subtracted from the uptake rates. Protein concentrations in cell lysates were determined with the Bradford method. TC uptake is expressed as pmol/mg protein. Uptake and unspecific binding was measured in three dishes per condition per cell preparation.
Cloning of the Rat PKC⑀ and Human PKC␣ and Transfection into HepG2 Cells-In order to clone the rat PKC⑀ or the human PKC␣, respectively, reverse transcription was performed using SuperScript II reverse transcriptase (Invitrogen, Karlsruhe, Germany) and oligo(dT) as a primer. The templates were mRNA from rat brain and from HepG2 cells, respectively.
For the subsequent PCR the forward primers were 5Ј-ATCCGCTA-GCGAATTCCGGAATCCGGCGAG-3Ј and 5Ј-ATCCGCTAGCGGAGC-AAGAGGTGGTTGG-3Ј, respectively. They contained an NheI restriction site and started in front of the 5Ј-untranslated region of rat PKC⑀ and human PKC␣, respectively (according to the sequence with the accession numbers M18331 and NM002737.1, respectively). The reverse primers were 5Ј-CCGCGGTACCCAGGGCATCAGGTCTTCA-CC-3Ј and 5Ј-CCGCGGTACCCATACTGCACTCTGTAAG-3Ј, respectively, where the stop codons were replaced by KpnI restriction sites. The resulting PCR products were cloned into the pGEM-T vector (Promega, Mannheim, Germany). After propagation in Escherichia coli inserts were excised with NheI and KpnI and were ligated into the vector pEYFP-N1 (Clontech, Palo Alto, CA) in frame to the N terminus of the enhanced yellow fluorescent protein. The sequences of the resulting plasmids (PKC⑀-YFP and PKC␣-YFP) were confirmed by sequencing.
HepG2 cells were cultured in Dulbecco's modified Eagle's mediumNutrimix F12 with 10% fetal calf serum. PKC⑀-YFP, PKC␣-YFP, or MARCKS-GFP were transfected into HepG2 cells with LipofectAMINE 2000 according to the manufacturer's guidelines (Invitrogen). 24 -48 h later cells were analyzed by confocal microscopy.
Confocal Laser Scanning Microscopy-Immunostaining and confocal laser-scanning microscopy were performed as described in Ref. 7 using a Leica TCS-NT confocal laserscanning system mounted on an inverted microscope. Identical settings were used to compare liver sections from different experimental conditions. Cross-talk of fluorochromes was excluded by the use of the acousto optical tunable filter. The entire depth of a section was scanned in 0.5-m steps. The resulting stacks of pictures were mounted as single projections.
HepG2 cells transfected with PKC⑀-YFP, PKC␣-YFP, or MARCKS-GFP were cultured on 12-mm glass cover slips. 24 -48 h after transfection coverslips were placed in a bath holder at 37°C and covered with medium. Cells were selected according to the expression of PKC⑀-YFP, PKC␣-YFP, or MARCKS-GFP. After brief adjustments of the microscope (excitation at 488 nm, emission at Ͼ510 nm), confocal pictures of HepG2 cells were taken in regular intervals (10 s to 1 min). After 2 min, PMA (100 nmol/liter) or Ttx (100 nmol/liter) were added to the medium, and cells were scanned for up to 60 min. Gö6976 (1 mol/liter) or Gö6850 (1 mol/liter) were added 30 min before microscopy was started. In the case of PKC⑀ PMA was applied to the medium at the end of Ttx treatment to finally prove translocation of PKC⑀-YFP.
Statistics-Data were reproduced from at least three perfusions or cell preparations. Values are given as means Ϯ S.D. (Western blots, uptakes) or S.E. (perfusions). The two-sided Student's t test was used for statistical analysis, with a p Ͻ 0.05 considered to be statistically significant.
RESULTS
Phorbolester-induced Cholestasis-PMA (10 nmol/liter) induced cholestasis in perfused rat livers and reduced bile secretion by 77% from 3.25 Ϯ 0.22 to 0.75 Ϯ 0.36 l/g liver/min (n ϭ 4) after 60 min in the presence of 100 mol/liter taurocholate ( Fig. 1) . Taurocholate excretion was similarly reduced by 78% from 201 Ϯ 16 to 45 Ϯ 21 nmol/g liver/min (n ϭ 4) ( Fig. 1) indicating that taurocholate was the major driving force for bile secretion in the experimental setting used. After 60 min of LDH release was 144 Ϯ 19 (n ϭ 3) and 100 Ϯ 13 milliunits/g liver/min (n ϭ 4) in the absence and presence of PMA, respectively, suggesting that PMA perfusion does not cause cell damage to the perfused livers.
Gö6850 (bisindolylmaleimide I, 1 mol/liter), a potent inhibitor of most Ca 2ϩ -dependent and Ca 2ϩ -independent PKC isoforms (22) diminished the effect of PMA on bile and taurocholate secretion by about 50% (Fig. 1 ). Gö6850 had no significant effect on these parameters by itself (not shown).
Gö6976, a carbazole derivate, is a selective inhibitor of Ca 2ϩ -dependent PKC isoforms with an IC 50 cPKC in Cholestasis (23) . Gö6976 (0.2 mol/liter) inhibited the PMA-induced cholestasis by 60% after 60 min of PMA-infusion ( Fig. 1) , suggesting that the PMA-dependent cholestasis is largely transmitted by Ca 2ϩ -dependent PKC isoforms. Ca 2ϩ -independent PKC isoforms such as nPKC␦ and nPKC⑀, which are activated by PMA, apparently contribute to cholestasis only to a smaller extent.
Activation of PKC isoforms is associated with their translocation from the cytosol to the plasma membrane (24 -26) . In order to investigate the effect of PMA on subcellular PKC localization, rat livers were separated into a membrane (M) and cytosolic fraction (C) as described under "Experimental Procedures." In control livers cPKC␣ was distributed in favor of the cytosol in contrast to nPKC⑀ ( Fig. 2A) . Liver samples were taken before or 20 min after Me 2 SO (control) or PMA perfusion. Both, cPKC␣ and nPKC⑀ translocated to the membrane fraction in PMA-treated but not in control livers (Fig. 2B) . The effect of PMA on both PKC isoforms was statistically significant. The amount of cPKC␣ in the membrane fraction increased 2.3 Ϯ 0.4-fold (n ϭ 3; p Ͻ 0.05) and was stronger compared with nPKC⑀ translocation (1.6 Ϯ 0.4-fold increase; n ϭ 3; p Ͻ 0.05)).
Calcium-dependent PKCs Mediate Cholestasis-Ttx, a diterpene-derivate of mezerein from the plant Thymelea hirsuta, is a selective activator of Ca 2ϩ -dependent PKC isoforms (27, 28) . In the perfused rat liver, Ttx at a concentration of 0.5 nmol/liter induced cholestasis (Fig. 3) and reduced bile flow and taurocholate excretion by ϳ80%. The cholestatic effect was dose-dependent (Table I ) resulting in an almost complete cholestasis at a Ttx concentration of 10 nmol/liter, while no signs of liver damage were detectable as assessed by LDH release (Table I) . Ttx at 0.5 nmol/liter induced a minor increase in portal pressure (Fig. 3) , which was more pronounced with increasing concentrations, therefore further experiments were performed with low Ttx concentrations (0.5 nmol/liter). Initial glucose output was 1.8 Ϯ 0,2 nmol/g liver/min (n ϭ 4) in controls and declined during perfusion. It was not significantly affected by Ttx (Fig. 3) . The pH was not affected by Ttx treatment. At the beginning it was 7.44 Ϯ 0.02 and 7.45 Ϯ 0.01 in control and Ttx livers, respectively, and increased to 7.49 Ϯ 0.03 and 7.51 Ϯ 0.01, respectively, after 60 min.
Gö6976 (200 nmol/liter) abolished the cholestatic effect of Ttx (Fig. 3) . This finding strongly suggests that Ttx-induced cholestasis is mediated by a Ca 2ϩ -dependent PKC isoform. Gö6976 itself had no significant effect (Fig. 3) .
In Ttx-treated livers (1 nmol/liter), cPKC␣ but not nPKC⑀ translocated to the membrane fraction (Fig. 4A ), in line with selective activation of cPKCs by Ttx. At 10-fold higher Ttx concentrations selectivity was still observed. The amount of membrane-bound cPKC␣ was 2.2 Ϯ 0.3-fold increased in Ttx The slight increases in portal pressure and glucose output induced by Ttx were not statistically significant. Gö6976 completely blocked the effects of Ttx ( ϭ Gö6976 ϩ Ttx). Gö6976 itself (E) had no significant effect on bile flow. Means Ϯ S.E., n ϭ 3 perfusions.
livers compared with control. The ratio of membrane-bound PKC␣ to total cPKC␣ significantly increased from 0.47 Ϯ 0.03 (control, n ϭ 3) to 0.65 Ϯ 0.06 (Ttx, n ϭ 3; p Ͻ 0.05) (Fig. 4B) . In contrast, the ratio of membrane-bound to total nPKC⑀ was not increased (Fig. 4B; In the membrane fraction of Ttx-treated livers a second band of higher electrophoretic mobility was detected by the cPKC␣ antibody (Fig.  4B) .
In order to provide further evidence for the specificity of Ttx compared with PMA, the Ca 2ϩ -independent PKC⑀ from rat and the Ca 2ϩ -dependent human PKC␣ were cloned as described in the methods section and were fused to the N terminus of the yellow fluorescent protein (YFP). Human HepG2 cells were transfected with PKC⑀-YFP or PKC␣-YFP and were analyzed 24 h later. In many unstimulated cells PKC⑀-YFP already localized to the cell membrane to some extent (e.g. Fig. 5A ). However, PMA (100 nmol/liter) always induced a strong and rapid translocation of PKC⑀-YFP to the cell membrane within 1-2 min (Fig. 5A and movie PMA and PKCe-YFP under Supplementary Materials). In contrast, no translocation to the plasma membrane was observed for PKC⑀-YFP when cells were treated with Ttx (100 nmol/liter) for 15 min, while PMA still exerted the translocation (Fig. 5B , and movie Ttx plus PMA and PKCe-YFP under Supplementary Materials). Activation of the Ca 2ϩ -dependent human PKC␣ as indicated by its translocation to the cell membrane was observed for both PKC activators, PMA (Fig. 5C) and Ttx (Fig. 5D) . It was noted that PKC␣ translocated faster in response to PMA compared with Ttx and that PKC⑀ translocated faster than PKC␣ in response to PMA. Taken together, the data are in line with a selective activation of cPKCs but not nPKCs by Ttx.
Differential Inhibition of PKC Isoforms by Gö6850 and Gö6976 -In order to investigate the efficacy of the two PKC inhibitors Gö6850 and Gö6976 in living cells, translocation of myristoylated alanine-rich C kinase substrates (MARCKS) was studied in transfected HepG2 cells. In unstimulated cells MARCKS is localized at the cell membrane because of its myristoylation at the N terminus and its basic residues in the 
FIG. 4. Ttx translocates cPKC␣ but not nPKC⑀ to the membrane.
A, liver specimens were collected just before (t 0 ) or 20 min after perfusion with Me 2 SO (Control) or Ttx (1 nmol/liter). An increase of cPKC␣ but not of nPKC⑀ in the membrane fraction was detected after 20 min of Ttx treatment compared with t 0 . X-fold changes in membranebound PKCs are given from three experiments (mean Ϯ S.D.). B, livers were perfused with or without 10 nmol/liter of Ttx for 60 min. Membrane (M) and cytosolic (C) fractions are shown. The ratios of membrane-bound to total amount of individual PKC isoforms from three livers are given. In Ttx livers the amount of membrane bound to total cPKC␣ significantly increased compared with control. In contrast, no shift of nPKC⑀ to the membrane fraction was detectable in Ttx-treated livers compared with controls. Means Ϯ S.D. * indicates statistical significance. 
cPKC in Cholestasis
effector domain (29) . Phosphorylation of multiple residues in the effector domain in response to PKC activation introduces negative charges into MARCKS and eventually leads to translocation of MARCKS into the cytosol (21) . Therefore subcellular localization of MARCKS was used as an indicator of PKC activity.
In transfected HepG2 cells, both, PMA (Fig. 6A) and Ttx (Fig.  6B) induced translocation of MARCKS to the cytosol, indicating PKC activation by these compounds. Gö6850 inhibited PMA- (Fig. 6C ) and Ttx- (Fig. 6D) induced MARCKS-translocation to the cytosol, indicating that Gö6850 affects all PMA-and Ttxsensitive PKC isoforms. In contrast, Gö6976 only inhibited MARCKS translocation induced by Ttx (Fig. 6F) but not by PMA (Fig. 6E) , which is in line with its inhibitory effect on Ca 2ϩ -dependent but not Ca 2ϩ -independent PKCs. The differential effects of PKC activators and inhibitors used in this study are summarized in Fig. 6G .
TUDC-induced Choleresis Is Independent of cPKCs-Tauroursodeoxycholate (TUDC, 20 mol/l) increased taurocholate excretion from 220 Ϯ 8 to 280 Ϯ 9 nmol/g liver/min (Fig. 7) as described earlier (17, 18) . When Gö6976 (200 nmol/liter) was added 20 min before TUDC, it did not affect the TUDC-dependent increase in TC excretion (Fig. 7) . This suggests that Ca 2ϩ -dependent PKC isoforms are not essential for TUDC signaling toward choleresis.
TC Uptake Is Not Impaired by PKC Activation in Isolated Hepatocytes-Taurocholate is taken up by the basolateral sodium taurocholate cotransporting polypeptide (Ntcp) and by organic anion-transporting polypeptides (Oatp) (30) . It is secreted by the canalicular bile salt export pump (Bsep). In order to differentiate whether PKC stimulation affects the transporter at the sinusoidal or the canalicular membrane, uptake of taurocholate was determined in isolated rat hepatocytes. 12 to 24 h after cell isolation, Ntcp was localized at the basolateral and canalicular proteins such as Mrp2 at the apical membrane (Fig. 8A) , demonstrating polarized localization of the transporters.
Cells cultured for 12 h were incubated 1 to 8 h with Ttx (100 nmol/liter) or PMA (100 nmol/liter). After treatment total amounts of cPKC␣ were determined in whole cell lysates by 
FIG. 7. TUDC-induced choleresis is not inhibited by Gö 6976.
Taurocholate excretion (100 mol/liter in the perfusate) into bile is increased by TUDC (20 mol/liter) in the perfused liver ( ). Gö6976 did not inhibit the choleretic effect of TUDC (E). Means Ϯ S.E., n ϭ 3.
Western blots. Expressional down-regulation indirectly verified activation of cPKC␣ (Fig. 8B) by Ttx and PMA.
The K m of Ntcp for TC transport is ϳ25 mol (31, 32) . In order to saturate transport TC-uptake was measured in the presence of 150 mol/liter of TC. TC uptake was almost linear during the first 10 min (Fig. 8D) . When cells were preincubated for 30 min with 1, 10, or 100 nmol/liter of Ttx or PMA, no inhibition of the initial TC uptake was observed compared with controls (Fig. 8D) . Likewise shorter preincubation (2 min) with Ttx or PMA (100 nmol/liter each) did not decrease initial TC uptake (not shown). These data suggest that cPKCs in cultured hepatocytes are responsive to PMA or Ttx treatment, but do not affect TC uptake across the sinusoidal membrane.
Effects of PMA and Ttx on Mrp2 and Bsep Localization-It was demonstrated recently that cholestasis can result from retrieval of canalicular transporter proteins into subapical vesicles (7, 9, 10, (33) (34) (35) . Here, cryosections of livers were immunostained and imaged by confocal laser scanning microscopy. In control livers immunoreactivity to Bsep was almost completely confined to the canaliculi (Fig. 9A) . In contrast, in PMA-treated livers (10 nmol/liter, 60 min) small Bsep-containing vesicle-like structures appeared in close vicinity to the canaliculi, and the canalicular shape became fuzzy (Fig. 9B) .
Similar results were obtained for Mrp2-immunoreactivity (not shown). This transporter retrieval of canalicular transporter proteins might contribute to the PMA-induced cholestasis.
Thymeleatoxin also induced Bsep retrieval in rat livers. While in control livers (Fig. 9C ) most Bsep immunoreactivity was localized within the canalicular domain delineated by the two lines of ZO-1, in Ttx livers (10 nmol/liter, 60 min) some pericanalicular Bsep staining was observed (Fig. 9D) . When Gö6976 was administered 20 min prior to Ttx, the effect of Ttx on Bsep retrieval was reversed (Fig. 9E) . It has to be noted that some amount of Bsep remains in the canalicular domain in Ttx-treated livers for up to 60 min although cholestasis is almost complete. These findings suggest that retrieval of transporter proteins from the canalicular membrane in response to selective stimulation of Ca 2ϩ -dependent PKC isoforms participate in the induction of cholestasis.
DISCUSSION
Although many inducers of cholestasis are known (for review see Refs. 3 and 36), the corresponding signal transduction cascades are incompletely understood (37) . PKCs were found to be involved in cholestasis, but the role of individual PKC isoforms in cholestasis is still controversial (8, 12, 37, 38) . Other studies have suggested a choleretic effect of PKC stimulation (19, 20) . To further specify the involvement of PKC isoforms in the regulation of bile secretion, different stimulators and inhibitors with different specificity for PKC isoforms were tested in this study.
Phorbolester are potent activators of PKC isoforms (39, 40) . PMA activates Ca 2ϩ -dependent and Ca 2ϩ -independent, but not atypical PKCs (41) . In this study, two inhibitors of PKC with different affinities for cPKCs and nPKCs were used to investigate the PMA-induced cholestasis (11, 13) . The inhibitor Gö6976 with high selectivity for cPKCs compared with nPKCs (28)) had a stronger inhibitory effect on PMA-induced cholestasis than Gö6850. Inhibition by Gö6976 was achieved at a concentration of 200 nmol/liter. In in vitro studies even micromolar concentrations of Gö6976 did not inhibit nPKCs (23) , indicating selectivity.
The finding that Ca 2ϩ -dependent PKCs are mediators of the PMA-induced cholestasis is strengthened by the experiments with Ttx, a selective activator of cPKCs (41, 42) . Ttx at very low concentrations (0.5 nmol/liter) induced cholestasis similar to PMA. Selectivity of Ttx (1 to 10 nmol/liter) in perfused rat liver is confirmed by selective translocation of cPKC␣ but not nPKC⑀ from the cytosolic to the membrane fraction (Fig. 4 ) in contrast to PMA, which translocated both isoforms (Fig. 2) . The selectivity of Ttx is underlined by the finding that PMA but not Ttx-induced translocation of the transfected rat PKC⑀ in HepG2 cells, while both PKC activators induce translocation of human PKC␣.
Furthermore, complete inhibition of the Ttx-induced cholestasis was achieved by Gö6976. The specificity of Gö6976 toward Ca 2ϩ -dependent PKC isoforms compared with Gö6850 was confirmed in this study. The subcellular localization of MARCKS was used to monitor PKC activity: MARCKS binds non-covalently to the cell membrane because of the myristate chain at its N terminus and because of electrostatic interactions of positively charged basic residues in the effector domain of MARCKS with negative charges of acidic membrane lipids (29, (43) (44) (45) . Phosphorylation of the basic residues by different PKC isoforms reverses the electrostatic interaction and cause translocation of MARCKS into the cytosol (21) . Here, HepG2 cells were transfected with a MARCKS-GFP fusion protein.
Gö6976 inhibited Ttx-but not PMA-induced MARCKS translocation to the cytosol. Apparently, activation of Ca 2ϩ -independent PKC isoforms by PMA is unaffected by Gö6976 and is sufficient for MARCKS translocation. Taken together, several lines of evidence suggest that Ca 2ϩ -dependent PKCs induce cholestasis in the perfused rat liver. Ca 2ϩ -independent PKC isoforms such as nPKC␦ or nPKC⑀ might contribute to cholestasis induced by PMA but not by Ttx. While PMA activates cPKCs and nPKCs, inhibition of the PMA-induced cholestasis by the selective cPKC-inhibitor Gö6976 was incomplete (Fig. 1) indicating an additional effect of the Gö6976-insensitive nPKCs. This would be in line with the finding that Ca 2ϩ -independent nPKC⑀ contributes to the cholestatic effect of taurolithocholate (12) .
Along with translocation of cPKC␣ a band of higher electrophoretic mobility was regularly observed in Ttx-treated livers (Fig. 4) . PKCs are phosphorylated at three phosphorylation sites (26) . Dephosphorylation of PKC␣ occurs after activation of PKC␣ and precedes its inactivation and degradation (46) . Therefore, the observed second band in Ttx-treated livers might represent the dephosphorylated PKC␣.
Limited proteolysis at an arginine within the pseudosubstrate sequence resulting in decreased molecular mass was described for PKC␤ after its activation (47) . Cleavage at an arginine within the pseudosubstrate sequence of PKC␣ would result in a loss of a 3-kDa fragment. Therefore this might be another explanation for the appearance of a second band after Ttx stimulation. Both, dephosphorylation or limited proteolysis, are indicators of PKC activation (46, 47) .
Other forms of cholestasis such as vasopressin-induced cholestasis involve reduced bile acid uptake by Ntcp (48, 49) . This possibility was investigated by uptake studies in isolated rat hepatocytes. Because hepatocytes transiently lose their cell polarity after isolation (9), cells were allowed to regain cell polarity during a 12-h culture period (Fig. 8A) .
In the presence of 150 mol/liter of taurocholate the initial TC uptake was 2.8 Ϯ 1.4 nmol/mg protein/min (mean Ϯ S.D., n ϭ 3) in line with results by others (32) . PMA and Ttx activated cPKC␣ as demonstrated indirectly by their expressional down-regulation (50), but both substances failed to reduce taurocholate uptake. These results are in line with previous findings, that PMA or vasopressin may inhibit the cAMP-induced TC uptake but not the "basal" taurocholate uptake rate (49) .
Retrieval of Bsep from the canalicular membrane upon PMA or Ttx stimulation (Fig. 9 ) might well contribute to cholestasis in rat liver as described for Mrp2 (13) . The functional significance of transporter retrieval is suggested by a tight association between transporter localization and bile secretion (7, 9, 33, 34). In this study, transporter retrieval is shown to accompany Ttx-induced cholestasis, but it cannot be decided whether transporter retrieval causes reduced bile acid secretion or whether it only follows transporter inactivation in the canalicular membrane. The latter possibility is supported by the finding that significant amounts of Bsep are still present in the canalicular membrane, even when Ttx cholestasis is almost complete. However, the data show that PMA and Ttx affect bile acid secretion rather than bile acid uptake.
Phosphorylation of mouse-Bsep by PKC␣ along with stimulation of bile acid secretion was reported to occur in transfected Sf9 cells (6) . The regulation of rat Bsep by PKC␣ remains to be determined. Furthermore, the Ttx-induced cholestasis might be mediated by PKC␤, the other Ca 2ϩ -dependent PKC isoform expressed in rat liver. PKC␣ might also regulate other targets such as tight junctions, which may result in cholestasis after loss of their integrity (51) .
Tauroursodeoxycholate (TUDC) has choleretic properties and is used in the treatment of cholestatic liver disease. TUDC was shown to induce translocation of cPKC␣ from the cytosol to the plasma membrane in isolated rat hepatocytes (20) , and it was suggested that the choleretic effect of TUDC depends on cPKC␣ (20) , although functional measurements were not performed. In this study no inhibition of the TUDC-induced choleresis could be achieved by Gö6976 (Fig. 7) at a concentration sufficient to inhibit the PMA-and Ttx-dependent cholestasis (Figs. 1 and 3) . It is concluded that translocation/activation of the Ca 2ϩ -dependent PKC␣ by TUDC (20) does not mediate its choleretic effect. Signaling by cPKC␣ is apparently overridden by the choleretic signaling of Erk (18) and the p38 MAPK (17) . Interestingly, inhibition of Erk-type MAP kinases by PD098059 not only inhibited the TUDC-induced choleresis but produced a slow cholestatic response by itself (18) , which might be attributed to the remaining activation of PKC␣ toward cholestasis.
Taken together it is concluded, that (I) Ca 2ϩ -dependent PKC isoforms induce cholestasis, (II) that this involves retrieval of Bsep and (III) that stimulation of Ca 2ϩ -dependent PKC␣ by TUDC (as shown by others, Refs. 19 and 20) does not explain the choleretic action of this bile acid.
